Scheer Rowlett & Associates Investment Management Ltd. increased its holdings in Nutrien Ltd (NYSE:NTR) by 0.5% during the 3rd quarter, Holdings Channel reports. The firm owned 1,711,374 shares of the company’s stock after buying an additional 8,814 shares during the period. Nutrien makes up approximately 6.3% of Scheer Rowlett & Associates Investment Management Ltd.’s investment portfolio, making the stock its 6th biggest position. Scheer Rowlett & Associates Investment Management Ltd.’s holdings in Nutrien were worth $98,742,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. 10 15 Associates Inc. grew its stake in shares of Nutrien by 1.8% in the second quarter. 10 15 Associates Inc. now owns 50,192 shares of the company’s stock worth $2,729,000 after purchasing an additional 897 shares during the last quarter. Morningstar Investment Services LLC grew its stake in shares of Nutrien by 6.8% in the second quarter. Morningstar Investment Services LLC now owns 14,693 shares of the company’s stock worth $799,000 after purchasing an additional 933 shares during the last quarter. Steward Partners Investment Advisory LLC grew its stake in shares of Nutrien by 28.4% in the third quarter. Steward Partners Investment Advisory LLC now owns 4,344 shares of the company’s stock worth $251,000 after purchasing an additional 962 shares during the last quarter. Fairfield Bush & CO. grew its stake in shares of Nutrien by 8.2% in the second quarter. Fairfield Bush & CO. now owns 13,182 shares of the company’s stock worth $717,000 after purchasing an additional 1,000 shares during the last quarter. Finally, Hellman Jordan Management Co. Inc. MA grew its stake in shares of Nutrien by 4.4% in the second quarter. Hellman Jordan Management Co. Inc. MA now owns 23,746 shares of the company’s stock worth $1,291,000 after purchasing an additional 1,000 shares during the last quarter. 66.70% of the stock is currently owned by institutional investors.
Shares of NTR traded down $0.65 during mid-day trading on Thursday, reaching $50.56. The company had a trading volume of 38,053 shares, compared to its average volume of 1,330,236. Nutrien Ltd has a 52 week low of $40.41 and a 52 week high of $58.99. The stock has a market cap of $31.35 billion, a P/E ratio of 40.97, a P/E/G ratio of 1.84 and a beta of 0.75.
Nutrien (NYSE:NTR) last issued its quarterly earnings results on Monday, November 5th. The company reported $0.47 EPS for the quarter, topping analysts’ consensus estimates of $0.44 by $0.03. Nutrien had a return on equity of 12.95% and a net margin of 1.74%. The firm had revenue of $4.03 billion for the quarter, compared to analysts’ expectations of $3.83 billion. The firm’s quarterly revenue was up 226.9% on a year-over-year basis. As a group, sell-side analysts forecast that Nutrien Ltd will post 2.65 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, January 17th. Stockholders of record on Monday, December 31st will be given a $0.43 dividend. This is a boost from Nutrien’s previous quarterly dividend of $0.40. This represents a $1.72 dividend on an annualized basis and a dividend yield of 3.40%. The ex-dividend date is Friday, December 28th.
Several research firms recently issued reports on NTR. Berenberg Bank began coverage on Nutrien in a research note on Wednesday, November 14th. They issued a “hold” rating and a $55.00 target price on the stock. Stephens set a $68.00 price objective on Nutrien and gave the company a “buy” rating in a research report on Thursday, November 8th. Credit Suisse Group set a $55.00 price objective on Nutrien and gave the company a “hold” rating in a research report on Wednesday, November 7th. TD Securities raised Nutrien from a “hold” rating to a “buy” rating and lifted their price objective for the company from $63.00 to $68.00 in a research report on Wednesday, November 7th. They noted that the move was a valuation call. Finally, Raymond James lifted their price objective on Nutrien from $67.00 to $70.00 and gave the company a “strong-buy” rating in a research report on Friday, November 2nd. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $62.67.
WARNING: This piece of content was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of US and international copyright law. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/12/06/scheer-rowlett-associates-investment-management-ltd-has-98-74-million-position-in-nutrien-ltd-ntr.html.
Nutrien Company Profile
Nutrien Ltd. produces and markets crop nutrients worldwide. The company offers potash, nitrogen, phosphate, and solid and liquid phosphate fertilizers; and phosphate feed, ammonium sulfate, and industrial acid products. It also retails seeds, crop protection and crop nutrient products, merchandise products, and agronomic services through operating 1,500 retail locations.
Featured Article: Municipal Bonds
Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd (NYSE:NTR).
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.